The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Use of serum and tissue biomarker analysis embedded in a phase II clinical trial of cytarabine in castration-refractory prostate cancer to investigate prostate cancer biology.
Saroj Niraula
No relevant relationships to disclose
Urban Emmeneger
No relevant relationships to disclose
Laurie Adams
No relevant relationships to disclose
Ian Tannock
No relevant relationships to disclose
Srikala S. Sridhar
No relevant relationships to disclose
Jennifer J. Knox
No relevant relationships to disclose
John R. Day
No relevant relationships to disclose
Jonathon Manthe
No relevant relationships to disclose
Jack Groskopf
No relevant relationships to disclose
Anthony Michael Joshua
No relevant relationships to disclose